Literature DB >> 17444041

[Clinical study of pars plana vitrectomy with silicone oil endotamponade in posttraumatic endophthalmitis on eyes without retinal detachment].

Zhenfang Wang1, Nuo Dong, Ying Kang, Xiaohong Liu, Qianzhong Cao, Dan Liang, Xiaofeng Lin.   

Abstract

PURPOSE: To assess the clinical effect of pars plana vitrectomy (PPV) with intravitreous antibiotic drugs or silicone oil endotamponade in post-traumatic endophthalmitis on eyes without detachment of the retina.
METHODS: Thirty cases of eyes with penetrating injury associated with endophthalmitis without retina detachment had been treated with PPV plus intravitreous antibiotic drugs or silicone oil tamponade. All the patients in the study received intravenous, subconjunctival and topical medications antibiotics.
RESULTS: All the patients were followed up for 3 to 12 months. Postoperative intraocular infection of 30 eyes (30 patients) were controlled. The best-corrected visual acuity was significantly improved in both groups postoperatively (P < 0.05). The rate of postoperative retinal detachment in the PPV combined with intravitreal antibiotics group was 21.1% (4/19) vs. 9% (1/11)in the PPV combined with silicone oil There was no significant difference in postoperative endotamponade group. There was no significant difference in postoperative complications between two groups.
CONCLUSIONS: PPV combined with silicone oil tamponade may have beneficial effect on the surgical treatment of traumatic bacterial endophthalmitis associated without retinal detachment, but the surgery may be used in some cases which have bad retinal condition or uncontrollable inflammation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17444041

Source DB:  PubMed          Journal:  Yan Ke Xue Bao        ISSN: 1000-4432


  1 in total

Review 1.  Role of intravitreal/intracameral antibiotics to prevent traumatic endophthalmitis - Meta-analysis.

Authors:  Thanigasalam Thevi; Adinegara Lutfi Abas
Journal:  Indian J Ophthalmol       Date:  2017-10       Impact factor: 1.848

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.